Literature DB >> 23693121

Risk factors for a poor hematopoietic stem cell mobilization.

Ayhan Donmez1, Fergun Yilmaz, Nihal Gokmen, Murat Tombuloglu.   

Abstract

Poor mobilization is an important problem in autologous stem cell transplantation. We retrospectively reviewed the data of 165 mobilized patients to identify possible risk factors for a poor stem cell mobilization. 27 patients (16.4%) were categorized as poorly mobilized. The poor mobilization ratio differed according to diagnosis (lymphoma: 25.4%, acute leukemia: 15.4%, amyloidosis: 14.3%, and multiple myeloma: 9.6%). Being diagnosed as lymphoma (odds ratio [OR]=6.02, p=0.001), advanced age (OR=1.05, p=0.007) and increased weight (OR=1.03, p=0.03) were found as possible risk factors. Being diagnosed as lymphoma was shown to be the most important risk factor for a poor mobilization. Leukapheresis staff should be aware of the increased risk of a poor mobilization in lymphoma patients and remobilization methods should be considered from the beginning.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hematopoietic stem cell mobilization; Poor mobilization; Risk factors

Mesh:

Year:  2013        PMID: 23693121     DOI: 10.1016/j.transci.2013.04.040

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  6 in total

Review 1.  High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Authors:  Tanya M Wildes; Amanda Cashen
Journal:  J Geriatr Oncol       Date:  2015-08-10       Impact factor: 3.599

2.  Pain-sensing neurons mobilize blood stem cells from bone marrow.

Authors:  Anastasia N Tikhonova; Iannis Aifantis
Journal:  Nature       Date:  2021-01       Impact factor: 49.962

Review 3.  A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes.

Authors:  Mohammad Rafiee; Mohammad Abbasi; Hassan Rafieemehr; Amin Mirzaeian; Mohieddin Barzegar; Vahid Amiri; Shaghayegh Shahsavan; Mohammad Hossein Mohammadi
Journal:  Health Sci Rep       Date:  2021-05-07

4.  Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study.

Authors:  Pellegrino Musto; Vittorio Simeon; Alberto Grossi; Francesca Gay; Sara Bringhen; Alessandra Larocca; Roberto Guariglia; Giuseppe Pietrantuono; Oreste Villani; Giovanni D'Arena; Carmela Cuomo; Clelia Musto; Fortunato Morabito; Maria Teresa Petrucci; Massimo Offidani; Elena Zamagni; Paola Tacchetti; Concetta Conticello; Giuseppe Milone; Antonio Palumbo; Michele Cavo; Mario Boccadoro
Journal:  Stem Cell Res Ther       Date:  2015-04-17       Impact factor: 6.832

5.  Circulating hematopoietic progenitors and CD34(+) cells predicted successful hematopoietic stem cell harvest in myeloma and lymphoma patients: experiences from a single institution.

Authors:  Jui-Ting Yu; Shao-Bin Cheng; Youngsen Yang; Kuang-Hsi Chang; Wen-Li Hwang; Chieh-Lin Jerry Teng
Journal:  J Blood Med       Date:  2016-02-05

6.  [Advances in mobilization of autologous hematopoietic stem cells].

Authors:  H Chen; K Y Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.